CTVA Corteva, Inc. Common Stock
$79.03
价格 · 八月 19, 2026
截至...的财报数据 七月 31, 2026
52周区间
$61–$91
61% of range
分析师评级
BUY
29 analysts
目标价
$92
+17% upside
P/E (TTM)
49.4
ROE
4.6%
净利润率
6.3%
关于 Corteva, Inc. Common Stock 公司概况（来自维基百科）
Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International.
阅读更多
Corteva, Inc. (also known as Corteva Agriscience) is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals (natural herbicides) that are sold in 110 countries. The company's name combines "cor" (Latin for "heart") with "teva" (the Hebrew word for nature). It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International.
History
After the merger of the Dow Chemical Company and DuPont to form DowDuPont in August 2017, Corteva was formed in March 2018 as a subsidiary handling the parent company's agriculture activities, which focused on seeds and crop protection. In June 2019, DowDuPont completed the corporate spin-off of the company and Corteva became a public company. Included in the spin-off was E. I. du Pont de Nemours and Company, the former corporate entity of DuPont which was designated as the predecessor to Corteva and was renamed to EIDP, Inc. in January 2023.
In March 2019, Corteva commissioned Charles River Laboratories to test its new fungicide on 36 beagles. Corteva argued that such testing is required by regulatory authorities but, after outrage from the Humane Society of the United States, the company agreed to stop the tests and release the animals to Michigan Humane for adoption.
In February 2020, Corteva ceased production of the pesticide chlorpyrifos due to declining sales after the product was linked to neurological problems in children and following bans in the European Union and some US states.
In March 2023, the company acquired Stoller Group, a maker of natural pesticides for $1.2 billion. It also acquired Symborg, an expert in microbiological technologies based in Murcia, Spain. This was part of an overall strategy to grow and strengthen an emerging biologicals product portfolio.
In November 2024, the company partnered with BP to develop a low carbon intensive bio-feedstock for the production of aviation biofuel. Also in November 2024, the company acquired the naming rights to the Indiana Farmers Coliseum at the Indiana State Fairgrounds. In 2025, the company introduced Forcivo, a fungicide for corn and soybeans containing flutriafol, azoxystrobin, and fluindapyr and targeting tar spot, southern rust, and frogeye leaf spot. In September 2025, the Wall Street Journal reported the company was exploring a breakup that would separate its seed and pesticide businesses. The company confirmed it planned to separate the businesses in October 2025. In May 2026, Corteva announced the name Vylor for its seed and genetics business.
Legal issues
In July 2020, a U.S. appeals court ruled that Corteva can continue to sell Enlist Duo, which contains 2,4-D choline and glyphosate, after environmentalists attempted to block sales of the chemical due to its claimed negative effects on plants and wildlife. However, the court ruled that the U.S. Environmental Protection Agency properly relied on studies that showed that the volatility of 2,4-D choline salt will not cause unreasonable harm to the environment.
In August 2022, Bayer sued Corteva for breach of contractual obligations related to the development and commercialization of E3 soybeans. Corteva then sued Bayer, alleging that Bayer infringed upon its patents on a gene used in Enlist Corn, which is resistant to herbicides such as Roundup. In May 2025, the case was paused until the US Supreme Court considers whether to take up a separate patent-related case.
In September 2022, the Federal Trade Commission sued Syngenta and Corteva, challenging certain US-based discount programs that allegedly block and restrict generic competition from pesticide markets. In January 2024, a federal judge denied a motion to dismiss the lawsuit.
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
CTVA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$79.03
市值
$53.12B
P/E (TTM)
49.4
每股收益 (TTM)
$1.60
营收 (TTM)
$17.40B
股息收益率
0.89%
ROE
4.6%
负债/权益
0.0
52周区间
$61 – $91
CTVA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$17.40B
2023-12-31
→
2025-12-31
EPS
$1.60
2023-12-31
→
2025-12-31
自由现金流
$2.81B
2023-12-31
→
2025-12-31
利润率
6.3%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CTVA
同行中位数
P/E (TTM)
49.4
36.4
P/S (TTM) (市销率 (TTM))
3.1
1.3
P/B (市净率)
2.2
1.4
EV / EBITDA (企业价值 / EBITDA)
41.0
—
Price / FCF (股价/自由现金流)
18.9
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CTVA
同行中位数
Net Profit Margin (净利润率)
6.3%
3.7%
ROA
2.6%
2.3%
ROE
4.6%
1.6%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CTVA
同行中位数
Debt / Equity (负债/股东权益比率)
0.0
—
Current Ratio (流动比率)
1.4
1.9
Quick Ratio (速动比率)
0.8
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CTVA
同行中位数
Revenue YoY (营收同比增长)
2.9%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-0.10%
—
Revenue CAGR 5Y (营收5年复合年增长率)
4.1%
—
EPS YoY
23.1%
—
Net Income YoY (净利润同比增长)
20.6%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CTVA
同行中位数
Payout Ratio (派息率)
43.4%
—
股息 收益率、派息率、股息历史、5年CAGR
股息收益率
0.89%
派息率
43.4%
5年股息复合年增长率 (CAGR)
—
| 除息日 | 金额 |
|---|---|
| 2026年6月1日 | $0.1800 |
| 2026年3月2日 | $0.1800 |
| 2025年12月1日 | $0.1800 |
| 2025年9月2日 | $0.1800 |
| 2025年6月2日 | $0.1700 |
| 2025年3月3日 | $0.1700 |
| 2024年12月2日 | $0.1700 |
| 2024年9月3日 | $0.1700 |
| 2024年6月4日 | $0.1600 |
| 2024年2月29日 | $0.1600 |
| 2023年11月30日 | $0.1600 |
| 2023年8月31日 | $0.1600 |
| 2023年5月31日 | $0.1500 |
| 2023年2月28日 | $0.1500 |
| 2022年11月10日 | $0.1500 |
| 2022年8月11日 | $0.1500 |
| 2022年5月12日 | $0.1400 |
| 2022年2月28日 | $0.1400 |
| 2021年11月10日 | $0.1400 |
| 2021年8月12日 | $0.1400 |
CTVA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
29 位分析师
- 强烈买入 7 24.1%
- 买入 13 44.8%
- 持有 9 31.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
20 位分析师 · 2026-08-17
中位数
$95.00
平均值
$92.30
现在
$79.03
最低
$78.00
最高
$103.00
中位数目标
$95.00
+20.2%
平均目标
$92.30
+16.8%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.19%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $2.30 | $2.27 | 0.03% |
| 2026年3月31日 | $1.50 | $1.20 | 0.30% |
| 2025年12月31日 | $0.22 | $0.22 | -0.00% |
| 2025年9月30日 | $-0.23 | $-0.54 | 0.31% |
| 2025年6月30日 | $2.20 | $1.93 | 0.27% |
| 2025年3月31日 | $1.13 | $0.90 | 0.23% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CTVA | $45.06B | 41.9 | 2.9% | 6.3% | 4.6% | — |
| CF | $11.88B | 8.6 | 19.3% | 25.4% | 36.6% | 38.5% |
| MOS | — | 14.2 | 8.4% | — | — | — |
| SMG | $3.29B | 23.1 | -3.9% | 4.2% | -44.8% | 30.6% |
| UAN | — | 11.0 | 15.4% | 16.3% | — | — |
| FMC | — | -0.8 | -18.3% | -64.6% | -68.3% | 37.0% |
| IPI | $364M | 32.6 | 17.1% | 3.8% | 2.3% | 18.4% |
| AVD | — | -2.2 | -5.9% | -9.7% | -23.6% | 28.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.40B | $16.91B | $17.23B | $17.45B | $15.65B | $14.22B | $13.85B | $14.29B | |
| Cost of Revenue | $9.17B | $9.53B | $9.92B | $10.44B | $9.22B | $8.51B | $8.57B | $9.95B | |
| R&D Expense | $1.47B | $1.40B | $1.34B | $1.22B | $1.19B | $1.14B | $1.15B | $1.35B | |
| SG&A Expense | $3.49B | $3.20B | $3.18B | $3.17B | $3.21B | $3.04B | $3.06B | $3.04B | |
| Interest Income | $136M | $132M | $283M | $124M | $77M | $56M | $59M | $86M | |
| Other Non-op | $-570M | $-300M | $-448M | $-60M | $1.35B | $212M | $215M | $249M | |
| Pretax Income | $1.69B | $1.27B | $1.09B | $1.43B | $2.35B | $675M | $-316M | $-6.81B | |
| Income Tax | $484M | $412M | $152M | $210M | $524M | $-81M | $-46M | $-31M | |
| Net Income | $1.09B | $907M | $735M | $1.15B | $1.76B | $681M | $-959M | $-5.07B | |
| EPS (Basic) | $1.60 | $1.31 | $1.04 | $1.59 | $2.39 | $0.91 | $-1.28 | $-6.76 | |
| EPS (Diluted) | $1.60 | $1.30 | $1.03 | $1.58 | $2.37 | $0.91 | $-1.28 | $-6.76 | |
| Shares (Basic) | 680,000,000 | 693,700,000 | 709,000,000 | 720,800,000 | 735,900,000 | 748,700,000 | 749,500,000 | 749,400,000 | |
| Shares (Diluted) | 681,400,000 | 696,000,000 | 711,900,000 | 724,500,000 | 741,600,000 | 751,200,000 | 749,500,000 | 749,400,000 | |
| EBITDA | $1.20B | $1.23B | $1.21B | $1.22B | · | · | $1.60B | · |
资产负债表 27
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.52B | $3.11B | $2.64B | $3.19B | $4.46B | $3.53B | $1.76B | $2.27B | |
| Short-term Investments | $9M | $63M | $98M | $124M | $86M | $269M | $5M | $5M | |
| Receivables | $4.88B | $4.45B | $4.21B | $4.17B | $3.44B | $3.75B | $4.22B | $3.65B | |
| Inventory | $5.67B | $5.43B | $6.90B | $6.81B | $5.18B | $4.88B | $5.03B | $5.31B | |
| Other Current Assets | $767M | $820M | $1.13B | $968M | $1.01B | $1.17B | $1.19B | $1.04B | |
| Current Assets | $17.34B | $15.10B | $16.26B | $16.80B | $15.55B | $14.77B | $13.52B | $22.97B | |
| PP&E (Net) | $4.22B | $4.10B | $4.29B | $4.25B | $4.33B | $4.40B | $4.55B | $4.54B | |
| PP&E (Gross) | $9.55B | $9.07B | $8.96B | $8.55B | $8.36B | $8.25B | $7.87B | $7.34B | |
| Accum. Depreciation | $5.33B | $4.97B | $4.67B | $4.30B | $4.04B | $3.86B | $3.33B | $2.80B | |
| Goodwill | $10.46B | $10.41B | $10.61B | $9.96B | $10.11B | $10.27B | $10.23B | $10.19B | |
| Intangibles | $8.30B | $8.88B | $9.63B | $9.34B | $10.04B | $10.75B | $11.42B | $12.05B | |
| Other Non-current Assets | $2.04B | $1.81B | $1.52B | $1.69B | $1.80B | $1.94B | $2.33B | $1.93B | |
| Total Assets | $42.84B | $40.83B | $43.00B | $42.62B | $42.34B | $42.65B | $42.40B | $108.68B | |
| Accounts Payable | $4.40B | $4.04B | $4.28B | $4.89B | $4.13B | $3.62B | $3.70B | $3.80B | |
| Accrued Liabilities | $3.10B | $2.10B | $2.35B | $2.25B | $2.07B | $2.15B | $4.43B | $4.00B | |
| Current Liabilities | $12.12B | $10.39B | $10.41B | $10.74B | $9.56B | $8.55B | $8.24B | $13.31B | |
| Capital Leases | $293M | $342M | $355M | $331M | $338M | $391M | $426M | $67M | |
| Deferred Tax | $251M | $478M | $899M | $1.12B | $1.22B | $893M | $920M | $1.48B | |
| Other Non-current Liabilities | $1.96B | $1.71B | $1.65B | $1.68B | $1.72B | $1.87B | $2.19B | $1.79B | |
| Total Debt | $782M | $500M | $196M | $0 | $1M | $1M | $1M | · | |
| Common Stock | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $0 | |
| Paid-in Capital | $27.00B | $27.20B | $27.75B | $27.85B | $27.75B | $27.71B | $28.00B | $0 | |
| Retained Earnings | $-67M | $55M | $-41M | $250M | $524M | $0 | $-425M | $0 | |
| AOCI | $-2.80B | $-3.47B | $-2.68B | $-2.81B | $-2.90B | $-2.89B | $-3.27B | $-3.36B | |
| Stockholders' Equity | $24.14B | $23.79B | $25.04B | $25.30B | $25.38B | $24.82B | $24.31B | $74.66B | |
| Liabilities + Equity | $42.84B | $40.83B | $43.00B | $42.62B | $42.34B | $42.65B | $42.40B | $108.68B | |
| Shares Outstanding | 672,163,000 | 685,595,000 | 701,260,000 | 713,419,000 | 726,527,000 | 743,458,000 | 748,577,000 | · |
现金流 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.20B | $1.23B | $1.21B | $1.22B | $1.24B | $1.18B | $1.60B | $2.79B | |
| Amort. of Intangibles | $644M | $685M | $683M | $702M | $722M | $682M | $475M | $391M | |
| Restructuring | $146M | $288M | $336M | $363M | · | · | · | · | |
| Other Non-cash | $1.11B | $11M | $-177M | $-1.50B | · | · | $430M | · | |
| Operating Cash Flow | $3.41B | $2.15B | $1.77B | $872M | $2.73B | $2.06B | $1.07B | $483M | |
| CapEx | $591M | $597M | $595M | $605M | $573M | $475M | $1.16B | $1.50B | |
| Investing Cash Flow | $-543M | $-589M | $-1.99B | $-632M | $-362M | $-674M | $-904M | $-505M | |
| Debt Issued | $1.73B | $3.07B | $3.43B | $1.36B | $419M | $2.44B | $1.00B | $756M | |
| Net Debt Issued | $-141M | $187M | $1.12B | $218M | $-2M | $998M | $-5.80B | · | |
| Stock Repurchased | $1.07B | $1.01B | $756M | $1.00B | $950M | $275M | $25M | $0 | |
| Net Stock Activity | $-1.07B | $-1.01B | $-756M | $-1.00B | $-950M | $-275M | $-25M | · | |
| Dividends Paid | $475M | $458M | $439M | $418M | $397M | $-388M | $-194M | $0 | |
| Financing Cash Flow | $-1.64B | $-1.20B | $-99M | $-1.18B | $-1.27B | $303M | $-2.93B | $-2.62B | |
| Net Change in Cash | $1.30B | $264M | $-460M | $-1.22B | $963M | $1.70B | $-2.85B | $-2.89B | |
| Taxes Paid | $750M | · | · | · | · | · | · | · | |
| Free Cash Flow | $2.81B | $1.55B | $1.17B | $267M | · | · | $-93M | · |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 6.3% | 5.4% | 4.3% | 6.6% | 11.2% | 4.8% | -6.9% | · | |
| Pretax Margin | 9.7% | 7.5% | 6.3% | 8.2% | 15.0% | 4.8% | -2.3% | · | |
| EBITDA Margin | 6.9% | 7.3% | 7.0% | 7.0% | · | · | 11.6% | · | |
| ROA | 2.6% | 2.2% | 1.7% | 2.8% | 4.2% | 1.6% | -2.2% | · | |
| ROE | 4.6% | 3.7% | 2.9% | 4.6% | 7.0% | 2.8% | -3.9% | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.5 | 1.6 | 1.6 | 1.6 | 1.7 | 1.6 | · | |
| Quick Ratio | 0.8 | 0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 0.7 | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | · | |
| Inventory Turnover | 1.7 | 1.7 | 1.5 | 1.7 | 1.9 | 1.8 | 1.8 | · | |
| Receivables Turnover | 3.7 | 3.9 | 4.2 | 4.5 | 4.6 | 4.1 | 3.4 | · |
增长率 9
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.9% | -1.8% | -1.3% | 11.5% | 10.1% | · | · | · | |
| Revenue CAGR 3Y | -0.10% | 2.6% | 6.6% | · | · | · | · | · | |
| Revenue CAGR 5Y | 4.1% | · | · | · | · | · | · | · | |
| EPS YoY | 23.1% | 26.2% | -34.8% | -33.3% | 160.4% | · | · | · | |
| EPS CAGR 3Y | 0.42% | -18.1% | 4.2% | · | · | · | · | · | |
| EPS CAGR 5Y | 11.9% | · | · | · | · | · | · | · | |
| Net Income YoY | 20.6% | 23.4% | -35.9% | -34.8% | 158.3% | · | · | · | |
| Net Income CAGR 3Y | -1.6% | -19.8% | 2.6% | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.9% | · | · | · | · | · | · | · |
估值 (TTM) 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.40B | $16.91B | $17.23B | $17.45B | $15.65B | $14.22B | $13.85B | · | |
| Net Income TTM | $1.09B | $907M | $735M | $1.15B | $1.76B | $681M | $-959M | · | |
| Market Cap | $45.06B | $39.05B | $33.60B | $41.93B | $34.35B | $28.79B | $22.13B | · | |
| Enterprise Value | $41.31B | $36.38B | $31.06B | $38.62B | $29.81B | $24.99B | $20.36B | · | |
| P/E | 41.9 | 43.8 | 46.5 | 37.2 | 19.9 | 42.5 | -23.1 | · | |
| P/S | 2.6 | 2.3 | 2.0 | 2.4 | 2.2 | 2.0 | 1.6 | · | |
| P/B | 1.9 | 1.6 | 1.3 | 1.7 | 1.4 | 1.2 | 0.9 | · | |
| P / Tangible Book | 8.4 | 8.7 | 7.0 | 7.0 | 6.6 | 7.6 | · | · | |
| P / Cash Flow | 13.2 | 18.2 | 19.0 | 48.1 | 12.6 | 13.9 | 20.7 | · | |
| P / FCF | 16.0 | 25.2 | 28.6 | 157.1 | · | · | -237.9 | · | |
| EV / EBITDA | 34.3 | 29.7 | 25.6 | 31.6 | · | · | 12.7 | · | |
| EV / FCF | 14.7 | 23.5 | 26.5 | 144.6 | · | · | -218.9 | · | |
| EV / Revenue | 2.4 | 2.2 | 1.8 | 2.2 | 1.9 | 1.8 | 1.5 | · | |
| Dividend Yield | 1.1% | 1.2% | 1.3% | 1.0% | 1.2% | -1.4% | -0.88% | · | |
| Earnings Yield | 2.4% | 2.3% | 2.1% | 2.7% | 5.0% | 2.4% | -4.3% | · | |
| Payout Ratio | 43.4% | 50.5% | 59.7% | -36.4% | -22.6% | -57.0% | 20.2% | · | |
| Annual Payout | $475M | $458M | $439M | $418M | $397M | $-388M | $-194M | · |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.38B | $4.91B | $3.91B | $2.62B | $6.46B | $4.42B | $3.98B | $2.33B | $6.11B | $4.49B | $3.71B | $2.59B | $6.04B | $4.88B | $3.83B | $2.78B | |
| Cost of Revenue | $2.72B | $2.37B | $2.25B | $1.64B | $2.93B | $2.34B | $2.50B | $1.56B | $2.92B | $2.55B | $2.37B | $1.65B | $3.14B | $2.77B | $2.51B | $1.88B | |
| R&D Expense | $388M | $341M | $413M | $351M | $375M | $335M | $365M | $348M | $357M | $332M | $357M | $335M | $329M | $316M | $340M | $312M | |
| SG&A Expense | $1.16B | $877M | $860M | $725M | $1.16B | $751M | $735M | $671M | $1.05B | $736M | $735M | $670M | $1.04B | $726M | $764M | $657M | |
| Interest Income | $27M | $34M | $44M | $29M | $31M | $32M | $39M | $33M | $25M | $35M | $130M | $59M | $54M | $40M | $49M | $36M | |
| Other Non-op | $-115M | $-117M | $-665M | $-23M | $103M | $15M | $19M | $-107M | $-113M | $-99M | $-94M | $-149M | $-134M | $-71M | $-149M | $23M | |
| Pretax Income | $1.62B | $858M | $-530M | $-370M | $1.80B | $784M | $88M | $-633M | $1.34B | $482M | $-323M | $-444M | $1.08B | $776M | $2.45B | $-396M | |
| Income Tax | $408M | $133M | $7M | $-62M | $422M | $117M | $138M | $-114M | $282M | $106M | $-92M | $-129M | $204M | $169M | $-162M | $-74M | |
| Net Income | $1.16B | $720M | $-552M | $-320M | $1.31B | $652M | $-41M | $-524M | $1.05B | $419M | $-253M | $-321M | $714M | $595M | $-55M | $-331M | |
| EPS (Basic) | $1.73 | $1.07 | $-0.80 | $-0.47 | $1.92 | $0.95 | $-0.04 | $-0.76 | $1.51 | $0.60 | $-0.35 | $-0.45 | $1.00 | $0.84 | $-0.07 | $-0.46 | |
| EPS (Diluted) | $1.73 | $1.07 | $-0.80 | $-0.47 | $1.92 | $0.95 | $-0.05 | $-0.76 | $1.51 | $0.60 | $-0.35 | $-0.45 | $1.00 | $0.83 | $-0.07 | $-0.46 | |
| Shares (Basic) | 668,600,000 | 672,500,000 | -1,365,300,000 | 678,700,000 | 681,700,000 | 684,900,000 | -1,393,700,000 | 691,100,000 | 695,900,000 | 700,400,000 | -1,423,100,000 | 708,400,000 | 710,800,000 | 712,900,000 | -1,447,900,000 | 718,700,000 | |
| Shares (Diluted) | 669,800,000 | 673,600,000 | -1,367,000,000 | 678,700,000 | 683,100,000 | 686,600,000 | -1,396,000,000 | 691,100,000 | 698,100,000 | 702,800,000 | -1,426,400,000 | 708,400,000 | 713,700,000 | 716,200,000 | -1,451,800,000 | 718,700,000 | |
| EBITDA | · | $297M | · | · | $301M | $296M | · | · | · | $307M | · | · | · | · | · | · |
资产负债表 27
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.37B | $1.96B | $4.52B | $2.51B | $2.06B | $2.01B | $3.11B | $2.42B | $1.84B | $1.50B | · | $2.25B | $2.56B | $1.65B | · | $2.20B | |
| Short-term Investments | $0 | $2M | $9M | $77M | $76M | $1M | $63M | $72M | $120M | $153M | · | $108M | $53M | $85M | · | $119M | |
| Receivables | $5.83B | $7.26B | $4.88B | $5.05B | $5.96B | $6.76B | $4.45B | $4.26B | $5.17B | $6.32B | · | $4.01B | $5.25B | $6.88B | · | $3.64B | |
| Inventory | $4.44B | $5.20B | $5.67B | $5.31B | $4.32B | $5.13B | $5.43B | $5.67B | $4.89B | $6.18B | · | $6.32B | $5.63B | $6.58B | · | $5.42B | |
| Other Current Assets | $853M | $1.13B | $767M | $758M | $873M | $1.15B | $820M | $831M | $892M | $1.42B | · | $1.07B | $1.01B | $1.33B | · | $1.04B | |
| Current Assets | $16.36B | $17.39B | $17.34B | $16.44B | $16.00B | $16.59B | $15.10B | $15.65B | $15.36B | $17.16B | · | $16.33B | $17.21B | $18.33B | · | $15.04B | |
| PP&E (Net) | $4.18B | $4.18B | $4.22B | $4.20B | $4.15B | $4.11B | $4.10B | $4.21B | $4.16B | $4.21B | $4.29B | $4.32B | $4.31B | $4.27B | $4.25B | $4.18B | |
| PP&E (Gross) | $9.74B | $9.62B | $9.55B | $9.63B | $9.46B | $9.24B | $9.07B | $9.23B | $9.09B | $9.01B | · | $8.89B | $8.80B | $8.63B | · | $8.44B | |
| Accum. Depreciation | $5.57B | $5.43B | $5.33B | $5.43B | $5.30B | $5.14B | $4.97B | $5.03B | $4.93B | $4.81B | · | $4.57B | $4.49B | $4.36B | · | $4.26B | |
| Goodwill | $10.44B | $10.41B | $10.46B | $10.51B | $10.52B | $10.33B | $10.41B | $10.63B | $10.49B | $10.55B | $10.61B | $10.44B | $10.54B | $10.51B | $9.96B | $9.79B | |
| Intangibles | $8.01B | $8.15B | $8.30B | $8.43B | $8.58B | $8.72B | $8.88B | $9.08B | $9.24B | $9.45B | · | $9.79B | $9.98B | $10.14B | · | $9.46B | |
| Other Non-current Assets | $2.18B | $2.03B | $2.04B | $2.04B | $1.92B | $1.83B | $1.81B | $1.64B | $1.57B | $1.58B | · | $1.56B | $1.54B | $1.66B | · | $1.67B | |
| Total Assets | $41.64B | $42.72B | $42.84B | $42.20B | $41.76B | $42.12B | $40.83B | $41.91B | $41.46B | $43.62B | · | $43.11B | $44.19B | $45.50B | · | $40.65B | |
| Accounts Payable | $3.96B | $4.19B | $4.40B | $4.34B | $3.83B | $3.90B | $4.04B | $3.75B | $3.30B | $3.61B | · | $3.68B | $3.38B | $3.96B | · | $4.14B | |
| Accrued Liabilities | $2.95B | $2.99B | $3.10B | $2.66B | $2.90B | $2.33B | $2.10B | $2.19B | $2.50B | $2.57B | · | $2.27B | $2.89B | $2.48B | · | $2.12B | |
| Current Liabilities | $10.79B | $11.85B | $12.12B | $10.42B | $9.52B | $11.48B | $10.39B | $10.42B | $8.95B | $11.33B | · | $10.35B | $10.35B | $13.23B | · | $8.92B | |
| Capital Leases | · | · | $293M | · | · | · | $342M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $512M | $290M | $251M | $373M | $258M | $369M | $478M | $496M | $607M | $753M | · | $1.07B | $1.13B | $1.25B | · | $1.12B | |
| Other Non-current Liabilities | $1.96B | $1.90B | $1.96B | $2.04B | $1.92B | $1.72B | $1.71B | $1.56B | $1.56B | $1.59B | · | $1.71B | $1.72B | $1.69B | · | $1.62B | |
| Total Debt | $0 | $791M | · | $788M | $1.28B | $673M | · | $500M | $0 | $0 | · | $188M | $195M | $49M | · | $0 | |
| Common Stock | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | · | $7M | $7M | $7M | · | $7M | |
| Paid-in Capital | $26.89B | $26.86B | $27.00B | $27.04B | $27.01B | $26.96B | $27.20B | $27.52B | $27.50B | $27.47B | · | $27.89B | $27.88B | $27.84B | · | $27.82B | |
| Retained Earnings | $1.22B | $436M | $-67M | $834M | $1.53B | $587M | $55M | $98M | $992M | $302M | · | $325M | $1.01B | $487M | · | $614M | |
| AOCI | $-2.97B | $-2.94B | $-2.80B | $-2.66B | $-2.64B | $-3.27B | $-3.47B | $-2.89B | $-3.32B | $-3.01B | · | $-3.00B | $-2.68B | $-2.74B | · | $-3.59B | |
| Stockholders' Equity | $25.16B | $24.36B | $24.14B | $25.22B | $25.91B | $24.29B | $23.79B | $24.74B | $25.18B | $24.77B | · | $25.23B | $26.22B | $25.60B | · | $24.84B | |
| Liabilities + Equity | $41.64B | $42.72B | $42.84B | $42.20B | $41.76B | $42.12B | $40.83B | $41.91B | $41.46B | $43.62B | · | $43.11B | $44.19B | $45.50B | · | $40.65B | |
| Shares Outstanding | · | · | 672,163,000 | · | 679,879,000 | 683,026,000 | 685,595,000 | 689,170,000 | 693,617,000 | 697,800,000 | 701,260,000 | 704,880,000 | 709,516,000 | 710,678,000 | 713,419,000 | 716,225,000 |
现金流 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $339M | $297M | $306M | $300M | $301M | $296M | $302M | $306M | $312M | $307M | $312M | $306M | $306M | $287M | · | · | |
| Deferred Tax | $4M | $-35M | · | · | $0 | $-55M | · | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $194M | $160M | $159M | $162M | $161M | $162M | $164M | $170M | $174M | $177M | $175M | $174M | $174M | $160M | $166M | $178M | |
| Restructuring | $49M | $92M | $15M | $30M | $79M | $22M | $89M | $32M | $92M | $75M | $241M | $2M | $60M | $33M | · | · | |
| Other Non-cash | · | $-3.87B | · | · | · | $-3.06B | · | · | · | $-3.33B | · | · | · | · | · | · | |
| Operating Cash Flow | $-466M | $-2.89B | $4.38B | $193M | $947M | $-2.11B | $4.17B | $130M | $451M | $-2.61B | $4.37B | $-105M | $812M | $-3.31B | $3.02B | $-525M | |
| CapEx | $122M | $81M | $222M | $157M | $118M | $94M | $181M | $154M | $114M | $148M | $183M | $162M | $99M | $151M | $145M | $142M | |
| Investing Cash Flow | $-170M | $-77M | $-188M | $-157M | $-164M | $-34M | $-123M | $-161M | $-35M | $-270M | $-214M | $-229M | $-33M | $-1.51B | $-193M | $-4M | |
| Debt Issued | $600M | $268M | $87M | $429M | $577M | $637M | $25M | $488M | $884M | $1.68B | $2M | $0 | $2.80B | $626M | $23M | $563M | |
| Net Debt Issued | · | $246M | · | · | · | $623M | · | · | · | $1.49B | · | · | · | $570M | · | · | |
| Stock Repurchased | $250M | $250M | $301M | $250M | $250M | $270M | $252M | $253M | $252M | $252M | $171M | $253M | $80M | $252M | $200M | $200M | |
| Net Stock Activity | · | $-250M | · | · | · | $-270M | · | · | · | $-252M | · | · | · | $-252M | · | · | |
| Dividends Paid | $120M | $121M | $121M | $122M | $116M | $116M | $118M | $117M | $111M | $112M | $112M | $114M | $106M | $107M | $107M | $108M | |
| Financing Cash Flow | $1.14B | $389M | $-2.20B | $367M | $-808M | $995M | $-3.34B | $619M | $-248M | $1.77B | $-3.70B | $224M | $105M | $3.27B | $-1.84B | $557M | |
| Net Change in Cash | $478M | $-2.58B | $1.99B | $420M | $22M | $-1.13B | $666M | $615M | $127M | $-1.14B | $382M | $-187M | $895M | $-1.55B | $999M | $-151M | |
| Free Cash Flow | · | $-2.97B | · | · | · | $-2.20B | · | · | · | $-2.76B | · | · | · | $-3.46B | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 18.2% | 14.7% | · | -12.2% | 20.3% | 14.8% | · | -22.5% | 17.2% | 9.3% | · | -12.4% | 11.8% | 12.2% | · | -11.9% | |
| Pretax Margin | 25.5% | 17.5% | · | -14.1% | 27.9% | 17.8% | · | -27.2% | 21.9% | 10.7% | · | -17.1% | -17.9% | 15.9% | · | -14.3% | |
| EBITDA Margin | · | 6.1% | · | · | 4.7% | 6.7% | · | · | · | 6.8% | · | · | · | · | · | · | |
| ROA | 2.8% | 1.7% | · | -0.76% | 3.2% | 1.5% | · | -1.2% | 2.5% | 0.94% | · | -0.77% | 1.7% | 1.4% | · | -0.81% | |
| ROE | 4.5% | 3.0% | · | -1.3% | 5.1% | 2.7% | · | -2.1% | 4.1% | 1.7% | · | -1.3% | 2.7% | 2.3% | · | -1.3% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.6 | 1.7 | 1.4 | · | 1.5 | 1.7 | 1.5 | · | 1.6 | 1.7 | 1.4 | · | 1.7 | |
| Quick Ratio | 0.8 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 0.6 | 0.8 | 0.7 | · | 0.6 | 0.8 | 0.7 | · | 0.7 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.5 | · | 0.3 | 0.6 | 0.4 | · | 0.3 | 0.6 | 0.4 | · | 0.3 | 0.6 | 0.5 | · | 0.4 | |
| Receivables Turnover | 1.1 | 0.7 | · | 0.6 | 1.2 | 0.7 | · | 0.6 | 1.2 | 0.7 | · | 0.7 | 1.2 | 0.8 | · | 0.8 |
估值 (TTM) 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.36B | $18.40B | · | $15.82B | $19.31B | $17.35B | · | $15.52B | $19.24B | $18.01B | · | $16.30B | $19.96B | $18.51B | · | $16.00B | |
| Net Income TTM | $2.88B | $2.37B | · | $1.12B | $2.50B | $1.60B | · | $627M | $1.86B | $1.41B | · | $657M | $1.95B | $1.80B | · | $1.23B | |
| Market Cap | · | · | · | · | $50.67B | $42.98B | · | $40.52B | $37.41B | $40.24B | · | $36.06B | $40.66B | $42.86B | · | $40.93B | |
| Enterprise Value | · | · | · | · | $49.81B | $41.65B | · | $38.52B | $35.45B | $38.58B | · | $33.89B | $38.23B | $41.18B | · | $38.61B | |
| P/E | 19.9 | 24.1 | · | 41.2 | 20.6 | 27.4 | · | 65.3 | 20.3 | 29.1 | · | 55.6 | 21.2 | 24.3 | · | 33.8 | |
| P/S | · | · | · | · | 2.6 | 2.5 | · | 2.6 | 1.9 | 2.2 | · | 2.2 | 2.0 | 2.3 | · | 2.6 | |
| P/B | · | · | · | · | 2.0 | 1.8 | · | 1.6 | 1.5 | 1.6 | · | 1.4 | 1.6 | 1.7 | · | 1.6 | |
| P / Tangible Book | · | · | · | · | 7.4 | 8.2 | · | 8.1 | 6.9 | 8.4 | · | 7.2 | 7.1 | 8.7 | · | 7.3 | |
| P / Cash Flow | · | · | · | · | · | -20.4 | · | · | · | -15.4 | · | · | · | -12.9 | · | · | |
| P / FCF | · | · | · | · | · | -19.5 | · | · | · | -14.6 | · | · | · | -12.4 | · | · | |
| EV / EBITDA | · | · | · | · | 165.5 | 140.7 | · | · | · | 125.7 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -18.9 | · | · | · | -14.0 | · | · | · | -11.9 | · | · | |
| EV / Revenue | · | · | · | · | 2.6 | 2.4 | · | 2.5 | 1.8 | 2.1 | · | 2.1 | 1.9 | 2.2 | · | 2.4 | |
| Earnings Yield | 5.0% | 4.2% | · | 2.4% | 4.9% | 3.6% | · | 1.5% | 4.9% | 3.4% | · | 1.8% | 4.7% | 4.1% | · | 3.0% | |
| Payout Ratio | · | 16.8% | · | · | · | 17.8% | · | · | · | 26.7% | · | · | · | 18.0% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 收入 | $17.40B | — | — | $16.91B | — |
| 净收入 | $1.09B | — | — | $907M | — |
| 稀释后每股收益 (EPS) | $1.60 | — | — | $1.30 | — |
资产负债表
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.0 | — | — | 0.0 | — |
| 流动比率 | 1.4 | — | — | 1.5 | — |
| 速动比率 | 0.8 | — | — | 0.7 | — |
现金流
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 自由现金流 | $2.81B | — | — | $1.55B | — |
最新新闻 提及该公司的近期头条新闻
交易信号 近期买入/卖出信号，包含入场价和风险/回报比
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 1604 家申报者 · $31.4B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 134 (-80 与上一季度对比) | 96 (-2 与上一季度对比) | 508 (+34 与上一季度对比) | 486 (+12 与上一季度对比) | +100.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 34 位内幕人士 · 17 位高管 · 18 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Luther C Kissam IV | CEO, Crop Protection Business | 2026年6月1日 A | 25138 | 0 | 0 | $0 |
| Charles V. Magro | Chief Executive Officer | 2026年2月28日 F | 349214 | 0 | 0 | $0 |
| James C. Collins Jr. | Chief Executive Officer | 2021年8月10日 M | 354018 | 0 | 0 | $0 |
| David Paul Johnson | EVP, Chief Financial Officer | 2026年2月24日 A | 81828 | 0 | 0 | $0 |
| David J Anderson | EVP, Chief Financial Officer | 2024年4月12日 F | 95483 | 0 | 0 | $0 |
| Gregory R Friedman | Executive VP, CFO | 2021年3月1日 M | 58236 | 0 | 0 | $0 |
| Judd M O'Connor | EVP, Seed Business Unit | 2026年2月28日 F | 52207 | 0 | 0 | $0 |
| Robert D. King | EVP, Crop Protection Business | 2026年2月28日 F | 68664 | 0 | 1 | $-2766176 |
| Audrey Grimm | SVP, Chief People Officer | 2026年2月28日 F | 34641 | 0 | 0 | $0 |
| Samuel R Eathington | EVP, Chief Technology & Digital Officer | 2026年2月28日 F | 85048 | 0 | 0 | $0 |
| Brian Titus | VP, Controller and Principal Accounting Officer | 2026年2月28日 F | 10064 | 0 | 2 | $-636213 |
| Jennifer Amy Johnson | SVP, Chief Legal Officer | 2026年2月24日 A | 17216 | 0 | 0 | $0 |
| Cornel B Fuerer | SVP, Chief Legal and Public Affairs Officer, Secretary | 2025年5月13日 M | 101641 | 0 | 0 | $0 |
| Timothy P Glenn | EVP, Seed Business Unit | 2024年2月28日 F | 185070 | 0 | 0 | $0 |
| Meghan Cassidy | Senior Vice President, Chief Human Resources and Diversity Officer | 2022年3月2日 M | 55518 | 0 | 0 | $0 |
| Rajan Gajaria | EVP, Business Platforms | 2022年2月14日 F | 108046 | 0 | 0 | $0 |
| Neal Gutterson | SVP, Chief Technology Officer | 2020年11月17日 M | 22589 | 0 | 0 | $0 |
| Nayaki R Nayyar | 董事 | 2026年7月31日 A | 36754 | 0 | 0 | $0 |
| Janet Plaut Giesselman | 董事 | 2026年7月31日 A | 20248 | 0 | 0 | $0 |
| Christopher J. Policinski | 董事 | 2026年7月31日 A | 2768 | 0 | 0 | $0 |
| David C Everitt | 董事 | 2026年4月28日 A | 19738 | 0 | 0 | $0 |
| Klaus A Engel | 董事 | 2025年4月30日 A | 38568 | 0 | 0 | $0 |
| Karen H. Grimes | 董事 | 2025年4月30日 A | 15853 | 0 | 0 | $0 |
| Michael O. Johanns | 董事 | 2025年4月30日 A | 45088 | 0 | 0 | $0 |
| Marcos M Lutz | 董事 | 2025年4月30日 A | 61409 | 0 | 0 | $0 |
| Kerry J Preete | 董事 | 2025年4月30日 A | 15959 | 0 | 0 | $0 |
| Pat Ward | 董事 | 2025年4月30日 A | 35758 | 0 | 0 | $0 |
| Lamberto Andreotti | 董事 | 2025年4月30日 A | 37784 | 0 | 0 | $0 |
| Rebecca B. Liebert | 董事 | 2024年4月26日 A | 26661 | 0 | 0 | $0 |
| Lois D Juliber | 董事 | 2021年4月30日 A | 54277 | 0 | 0 | $0 |
| THOMAS LEE M | 董事 | 2020年5月13日 P | 26630 | 0 | 0 | $0 |
| Robert A Brown | 董事 | 2020年4月28日 A | 29273 | 0 | 0 | $0 |
| Edward D Breen | 董事 | 2020年2月14日 F | 123035 | 0 | 0 | $0 |
| Gregory R Page | — | 2026年4月28日 A | 69074 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 183 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| KROP · Global X Funds | 13.07% | 15313 NS | 2026年5月31日 | N-PORT |
| VEGI · iShares, Inc. | 9.75% | 186199 SH | 2026年8月8日 | 每日 |
| GUNR · FlexShares Trust | 5.00% | 4626314 NS | 2026年4月30日 | N-PORT |
| PBJ · Invesco Exchange-Traded Fund Trust | 4.92% | 68739 SH | 2026年8月8日 | 每日 |
| RSPM · Invesco Exchange-Traded Fund Trust | 3.79% | 91278 SH | 2026年8月8日 | 每日 |
| VAW · VANGUARD WORLD FUND | 3.72% | 1969938 SH | 2026年8月8日 | 每日 |
| FMAT · FIDELITY COVINGTON TRUST | 3.51% | 261178 NS | 2026年4月30日 | N-PORT |
| UYM · ProShares Trust | 3.14% | 16074 NS | 2026年5月31日 | N-PORT |
| PYZ · Invesco Exchange-Traded Fund Trust | 3.10% | 31549 SH | 2026年8月8日 | 每日 |
| NRES · DBX ETF Trust | 2.54% | 12028 NS | 2026年5月31日 | N-PORT |
| IYK · iShares Trust | 2.35% | 435506 SH | 2026年8月8日 | 每日 |
| ANEW · ProShares Trust | 2.35% | 2318 NS | 2026年5月31日 | N-PORT |
| MXI · iShares Trust | 1.63% | 75398 SH | 2026年8月8日 | 每日 |
| SZNE · Pacer Funds Trust | 1.05% | 1738 NS | 2026年4月30日 | N-PORT |
| QQWZ · Pacer Funds Trust | 0.98% | 5684 NS | 2026年4月30日 | N-PORT |
| COWZ · Pacer Funds Trust | 0.98% | 2207060 NS | 2026年4月30日 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0.98% | 4312594 SH | 2026年8月8日 | 每日 |
| CCNR · Financial Investors Trust | 0.95% | 46150 NS | 2026年4月30日 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 0.88% | 1885 NS | 2026年4月30日 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.76% | 1436 NS | 2026年4月30日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.76% | 992 NS | 2026年5月31日 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0.73% | 14431 NS | 2026年4月30日 | N-PORT |
| LRGC · AB Active ETFs, Inc. | 0.72% | 114960 NS | 2026年5月31日 | N-PORT |
| QLV · FlexShares Trust | 0.66% | 13832 NS | 2026年4月30日 | N-PORT |
| LGDX · Tidal Trust III | 0.61% | 10379 NS | 2026年4月30日 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.55% | 14549447 SH | 2026年8月8日 | 每日 |
| PEXL · Pacer Funds Trust | 0.51% | 2879 NS | 2026年4月30日 | N-PORT |
| IWS · iShares Trust | 0.49% | 1014066 SH | 2026年8月8日 | 每日 |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0.49% | 1255743 SH | 2026年8月8日 | 每日 |
| HUSV · First Trust Exchange-Traded Fund III | 0.45% | 4064 NS | 2026年4月30日 | N-PORT |
| SFGV · EA Series Trust | 0.44% | 63699 NS | 2026年5月29日 | N-PORT |
| REVS · Columbia ETF Trust I | 0.43% | 15123 NS | 2026年4月30日 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0.43% | 59771 NS | 2026年4月30日 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trus... | 0.42% | 7217 NS | 2026年5月31日 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund ... | 0.41% | 22444 NS | 2026年4月30日 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund ... | 0.40% | 21683 NS | 2026年4月30日 | N-PORT |
| IMCG · iShares Trust | 0.39% | 209025 SH | 2026年8月8日 | 每日 |
| IWR · iShares Trust | 0.37% | 2736404 SH | 2026年8月8日 | 每日 |
| IMCB · iShares Trust | 0.35% | 77275 SH | 2026年8月8日 | 每日 |
| FFLG · FIDELITY COVINGTON TRUST | 0.34% | 24414 NS | 2026年4月30日 | N-PORT |
| LRND · New York Life Investments ETF Trust | 0.32% | 11330 NS | 2026年4月30日 | N-PORT |
| IMCV · iShares Trust | 0.31% | 45916 SH | 2026年8月8日 | 每日 |
| DEUS · DBX ETF Trust | 0.30% | 10555 NS | 2026年5月29日 | N-PORT |
| ABCS · EA Series Trust | 0.29% | 414 NS | 2026年5月29日 | N-PORT |
| PALC · Pacer Funds Trust | 0.29% | 8114 NS | 2026年4月30日 | N-PORT |
| XOEF · iShares Trust | 0.28% | 837 SH | 2026年8月8日 | 每日 |
| FTLS · First Trust Exchange-Traded Fund III | 0.28% | 78226 NS | 2026年4月30日 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Inde... | 0.26% | 167445 SH | 2026年8月8日 | 每日 |
| CRBN · iShares Trust | 0.26% | 40238 SH | 2026年8月8日 | 每日 |
| USMV · iShares Trust | 0.26% | 829685 SH | 2026年8月8日 | 每日 |